Adherence to oral anticoagulation in secondary stroke prevention - The first year of direct oral anticoagulants

Journal of Stroke and Cerebrovascular Diseases

Volumn 24, Issue 1, 2015, Pages 78-82

  Sauer, Roland ^a   Sauer, Eva Maria ^a   Bobinger, Tobias ^a   Blinzler, Christian ^a   Huttner, Hagen B ^a   Schwab, Stefan ^a   Köhrmann, Martin ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

adherence; Atrial fibrillation; ischemic stroke; oral anticoagulation

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ANTICOAGULATION; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; RANKIN SCALE; STROKE PATIENT; SURVIVOR; ATRIAL FIBRILLATION; COMPLICATION; PATIENT COMPLIANCE; PROCEDURES; PROSPECTIVE STUDY; SECONDARY PREVENTION; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SECONDARY PREVENTION; STROKE;

EID: 84920665204     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.07.032     Document Type: Article

References (22)

1. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
2. S.E. Kimmel, Z. Chen, and M. Price The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study Arch Intern Med 167 2007 229 235
3. T.J. Bungard, W.A. Ghali, and K.K. Teo Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 2000 41 46
4. A.D. Waterman, P.E. Milligan, and L. Bayer Effect of warfarin nonadherence on control of the International Normalized Ratio Am J Health Syst Pharm 61 2004 1258 1264
5. K. Thorne, S. Jayathissa, and S. Dee Adherence and outcomes of patients prescribed dabigatran (Pradaxa) in routine clinical practice Intern Med J 44 2014 261 265
6. C. Weimar, J. Benemann, and Z. Katsarava Adherence and quality of oral anticoagulation in cerebrovascular disease patients with atrial fibrillation Eur Neurol 60 2008 142 148
7. G.F. Hamann, C. Weimar, and J. Glahn Adherence to secondary stroke prevention strategies-results from the German Stroke Data Bank Cerebrovasc Dis 15 2003 282 288
8. L.R. Tulner, J.P. Van Campen, and I.M. Kuper Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study Drugs Aging 27 2010 39 50
9. L.J. Lin, M.H. Cheng, and C.H. Lee Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation-A nationwide descriptive study in Taiwan Clin Ther 30 2008 1726 1736
10. H. Heidbuchel, P. Verhamme, and M. Alings European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation Europace 15 2013 625 651
11. S. Kopecky New anticoagulants for stroke prophylaxis in atrial fibrillation: assessing the impact on medication adherence Am J Cardiovasc Drugs 12 2012 287 294
12. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
13. S. Monte, A. Macchia, and F. Pellegrini Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation Eur Heart J 27 2006 2217 2223
14. G.Y. Lip, C. Laroche, and G.A. Dan 'Real-world' antithrombotic treatment in atrial fibrillation: the EUR Observational Research Programme Atrial Fibrillation General Pilot survey Am J Med 127 2014 519 529.e1
15. R. Oliveira, S. Grilo, and C. Moreira A quality study to improve prophylactic antithrombotic therapy prescribed to patients with atrial fibrillation Rev Port Cardiol 33 2014 89 94
16. A.B. Platt, A.R. Localio, and C.M. Brensinger Can we predict daily adherence to warfarin? Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study Chest 137 2010 883 889
17. X. Song, S.D. Sander, and H. Varker Patterns and predictors of use of warfarin and other common long-term medications in patients with atrial fibrillation Am J Cardiovasc Drugs 12 2012 245 253
18. A.B. Platt, A.R. Localio, and C.M. Brensinger Risk factors for nonadherence to warfarin: results from the IN-RANGE Study Pharmacoepidemiol Drug Saf 17 2008 853 860
19. D.G. Cruess, A.R. Localio, and A.B. Platt Patient attitudinal and behavioral factors associated with warfarin non-Adherence at outpatient anticoagulation clinics Int J Behav Med 17 2010 33 42
20. E.L. De Schryver, J. van Gijn, and L.J. Kappelle Non-Adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke J Neurol 252 2005 1316 1321
21. S. Schulman, B. Shortt, and M. Robinson Adherence to anticoagulant treatment with dabigatran in a real-world setting J Thromb Haemost 11 2013 1295 1299
22. T.M. Brown, K. Siu, and D. Walker Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation J Manag Care Pharm 18 2012 351 362